Medical management of children with thyrotoxicosis

Right Decisions
Back
SPEG (Scottish Paediatric Endocrine Group)
Medical management of children with thyrotoxicosis

Please update your RDS mobile app to version 4.7.1

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

Who should use this guideline

paediatricians
paediatric endocrinologists

Patients to whom this guideline applies

Children and young people under 16 years of age who have been diagnosed with
thyrotoxicosis.

Last reviewed: 01/01/2024
Next review date: 01/01/2024
Author: Clinical Guidelines Subgroup
Version: V2
Author email(s): nss.speg@nhs.scot
Approved by: SPEG Guidelines Group, SPEG Steering group
Document ID: NSD610-016.04

Acknowledgement
We gratefully acknowledge Dr Tim Cheetham, Royal Victoria Infirmary
Newcastle upon Tyne for much of this guideline which is based on his protocol for the BSPED RCT of
childhood thyrotoxicosis treatment.

Medical management of children with thyrotoxicosis

Who should use this guideline

Patients to whom this guideline applies

Summary

Introduction

Patient details to be recorded at diagnosis

Examination

Investigations

Treatment

Eye disease

Other causes of thyrotoxicosis

References